Indicators of renal glomerular and tubular functions in patients with beta-thalassaemia major: A cross sectional study at the Royal Hospital, Oman

Sultan Qaboos University Medical Journal

Volumn 11, Issue 1, 2011, Pages 69-76

  Mula Abed, Waad Allah S ^a   Al Hashmi, Huda S ^a   Al Muslahi, Muhanna N ^a  

^a ROYAL HOSPITAL   (Oman)

Author keywords

Beta thalassaemia; Glomerular; Oman; Renal function; Tubular

Indexed keywords

EID: 79957943701     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Rajab AG, Patton MA, Modell B. Study of hemoglobinopathies in Oman through a national register. Saudi Med J 2000; 21:1168-72.
2. AlKindi S, Al Zadjali S, Al Madhani A, Daar S, Al Haddabi H, Al Abri Q, et al. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin 2010; 34:135-44.
3. Al-Riyami A, Ebrahim GJ. Genetic blood disorders survey in the Sultanate of Oman. J Trop Pediatr 2003; 49:i1-20.
4. Al-Siliman A. Prevalence of beta-thalassarmia trait in premarital screening in Al-Hassa, Saudi Arabia. Ann Saudi Med 2006; 26:14-6.
5. Mohammed AM, Al-Hilli F, Nadkarni KV, Bhagwat GP, Bapat JP. Hemoglobinopathies and glucose-6- phosphate dehydrogenase deficiency in hospital births in Bahrain. Ann Saudi Med 1992; 12:536-9.
6. Miller CJ, Dunn EV, Berg B, Abdouni SF. A hematological survey of preschool children of the United Arab Emirates. Saudi Med J 2003; 24:609-13.
7. Karimi M, Jamalian N, Yarmohammadi H, Askarnejad A, Afrasiabi A, Hashemi A. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme. J Med Screen 2007; 14:62-6.
8. Cooley TB, Lee P. A series of cases of splenomegaly in children with anemia and peculiar changes. Trans Am Pediatr Soc 1925; 37:29-30.
9. Thein SL. Beta-thalassaemia. Baillieres Clin Haematol 1998; 11:91-126.
10. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, et al. Survival in medically treated patients with homozygous beta-thalassaemia. N Engl J Med 1994; 331:574-8.
11. Britton RS, Ramm GA, Olynyk J, Singh R, O'Neill R, Bacon BR. Pathophysiology of iron toxicity. Adv Exp Med Biol 1994; 356:239-53.
12. Burtis CA, Ashwood ER, Bruns DE, Eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 14th ed. St. Louis, Missouri: Elsevier Saunders, 2006.
13. Levey AS, Greene T, Kusek JW, Beck GL. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11:A0828.
14. Payne RB. Renal tubular reabsorption (TmP/GFR): indications and interpretation. Ann Clin Biochem 1998; 35:201-6.
15. Hill AB, Hill ID. Bradford Hill's Principles of Medical Statistics. 12th ed. London: Hodder Arnold, 1991.
16. Lamb EJ, Tomson CRV, Roderick PJ. Estimating kidney function in adults using formulae. Ann Clin Biochem 2005; 42:321-45.
17. Mula-Abed WA, Al-Hashmi HS, AlMuslahi MN, AlMuslahi HN, AlLamki MA. Prevalence of endocrinopathies in patients with beta-thalassaemia major: A cross-sectional study in Oman. Oman Med J 2008; 23:257-62.
18. Walter PB, Macklin EA, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, et al. Inflammation and oxidantstress in beta-thalassemia patients treated with iron chelators desferasirox (ICL670) or desferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica 2008; 93:817-25.
19. Ong-ajyooth L, Malasit P, Ong-ajyooth S, Fucharoen S, Pootrakul P, Vasuvattkul S, et al. Renal function in adult beta-thalassemia/Hb E disease. Nephron 1998; 78:156-61.
20. Kotopodis KP, Elisaf MS, Pappas HA, Theodorou JC, Milionis HJ, Bourantas KL, et al. Renal abnormalities in patients with sickle cell beta-thalassemia. J Nephrol 1997; 10:163-7.
21. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106:1777-82.
22. Gosling P. Proteinuria. In: Marshall WJ, Bangert SK, Eds. Clinical Biochemistry: Metabolic and Clinical Aspects. 2nd ed., New York: Elsevier, 2008: Pp. 156-73.
23. Aldudak B, Karabay Bayazit A, Noyan A, Ozel A, Anarat A, Sasmaz I, et al. Renal function in pediatric patients with beta-thalassemia major. Pediatr Nephrol 2000; 15:109-12.
24. Kalman S, Atay AA, Sakallioglu O, Ozgurtas T, Gok F, Kurt I, et al. Renal tubular function in children with beta-thalassemia minor. Nephrology 2005; 10:427-9.
25. Smolkin V, Halevy R, Levin C, Mines M, Sakran W, Ilia K, et al. Renal function in children with betathalassemia major and thalassemia intermedia. Pediatr Nephrol 2008; 23:1847-51.
26. Sumboonnanonda A, Malasit P, Tanphaichitr VS, Ong-ajyooth S, Sunthornchart S, Pattanakakitsakul S, et al. Renal tubular function in beta-thalassemia. Pediatr Nephrol 1998; 12:280-3.
27. Del Rio D, Stewart AJ, Pellergini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15:316-28.
28. Mundy GR. Factors regulating bone resorbing and bone forming cells. In: Mundy GR, Ed. Bone remodeling and its disorders. 2nd ed. London: Martin Dunitz, 1999. Pp. 45-82.
29. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL. Estrogens stimulate gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 1999; 140:4367-70.
30. Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE. The localization of androgen receptors in human bone. J Clin Endocrinol Metab 1997; 82:3493-7.
31. Dundar U, Kupesiz A, Ozdern S, Gilgil E, Tuncer T, Yesilipek A, et al. Bone metabolism and mineral density in patients with beta-thalassemia major. Saudi Med J 2007; 28:1525-9.
32. Voskaridou E, Terpos E. Pathogenesis and management of osteoporosis in thalassemia. Pediatr Endocrinol Rev 2008; 6:86-93.
33. Shaw NJ, Wheeldon J, Brocklebank JT. Indices of intact serum parathyroid hormone and renal excretion of calcium, phosphate, and magnesium. Arch Dis Child 1990; 65:1208-11.
34. Wikstrom B, Backman U, Danielson BG, Fellstrom B, Johansson G, Ljunghall S, et al. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism. Scand J Urol Nephrol 1981; 61:II:1-26.
35. Jaeger P, Portmann L, Ginalski JM, Jacquet AF, Temler E, Burckhardt P. Tubulopathy in nephrolithiasis: conseque rather than cause. Kidney Int 1986; 29:563-71.
36. Alpern RJ, Sakhaee K. Does hyperphosphaturia underlie hypercalciuria? Lancet 1997; 349:518-9.